Scientists have hijacked the herpes virus and turned it into a cancer-busting ally. A decade after the United States Food and Drug Administration (FDA) approved the first virus-based cancer therapy, ...
Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...
Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...
Pritelivir, a new oral therapy, was significantly more effective against herpes simplex virus (HSV) than a comparator treatment for immunocompromised patients with refractory infections, based on data ...
The idea that herpes infections trigger or contribute to Alzheimer's disease has been gaining favor among some scientists, raising hope that herpes treatments could slow the progression of Alzheimer's ...
Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...
You might expect a sexual partner to disclose a sexually transmitted infection. But you can’t rely on this – and ...
The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and 49 live with a genital herpes infection. That's equivalent to one in every ...
Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results